This announcement is a separate document:
哈三联：独立董事关于2023年度独立性情况的自查报告-刘洪泉
Harbin Medisan Pharmaceutical: Independent Directors' Self-Inspection Report on the 2023 Independence Situation - Liu Hongquan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.